These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3815599)

  • 1. Degradation kinetics of carumonam in aqueous solution.
    Matsuhisa Y; Umemoto K; Itakura K; Usui Y
    Chem Pharm Bull (Tokyo); 1986 Sep; 34(9):3779-90. PubMed ID: 3815599
    [No Abstract]   [Full Text] [Related]  

  • 2. Stability in aqueous solution of two monocyclic beta-lactam antibiotics: aztreonam and nocardicin A.
    Méndez R; Alemany T; Martín-Villacorta J
    Chem Pharm Bull (Tokyo); 1992 Dec; 40(12):3222-7. PubMed ID: 1294324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of the monocyclic beta-lactam antibiotic carumonam in plasma and urine by ion-pair and ion-suppression reversed-phase high-performance liquid chromatography.
    Egger HJ; Fischer G
    J Chromatogr; 1987 Sep; 420(2):357-72. PubMed ID: 3693507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and tissue penetration of carumonam, a new synthetic monobactam.
    McNulty CA; Garden GM; Ashby J; Wise R
    Antimicrob Agents Chemother; 1985 Sep; 28(3):425-7. PubMed ID: 4073864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative antibacterial activity of a new monobactam, carumonam (RO 17-2301, AMA 1080) on hospital bacteria resistant to beta lactams].
    Le Noc P; Croize J; Le Noc D
    Pathol Biol (Paris); 1987 May; 35(5):451-6. PubMed ID: 3302846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of carumonam after single and multiple 1- and 2-g dosage regimens.
    Bérubé D; Vallée F; Panneton AC; Bergeron MG; LeBel M
    Antimicrob Agents Chemother; 1988 Mar; 32(3):354-7. PubMed ID: 3364953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical study of carumonam].
    Takebe K; Tamura T; Endo K; Irie T; Sekino K; Uehara O; Sagara M; Okamoto K
    Jpn J Antibiot; 1987 Nov; 40(11):1917-22. PubMed ID: 3444030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antibacterial activity of carumonam and cefpirome on hospital strains resistant to gentamicin and cephalothin: comparison with other beta-lactam antibiotics, new fluoroquinolones, aminoglycosides and other antibiotics].
    Vanhoof R; Nyssen HJ; Nulens E; Roebben E; Hubrechts JM
    Pathol Biol (Paris); 1990 Jun; 38(6):634-7. PubMed ID: 2165238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergy study of carumonam and ceftazidime with aminoglycosides.
    Ahmet Z; Houang E
    J Antimicrob Chemother; 1987 Aug; 20(2):288-90. PubMed ID: 3312142
    [No Abstract]   [Full Text] [Related]  

  • 10. [In vitro activity of carumonam (RO 17-2301) on hospital bacteria].
    Soussy CJ; Le Van Thoi J; Duval JR
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):573-6. PubMed ID: 3534745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative bactericidal activity of cefixime, carumonam, enoxacin and roxithromycin with those of other antibiotics against resistant Haemophilus influenzae including beta-lactam tolerant strains.
    Bergeron MG; Lavoie GY; Boucher FD
    J Antimicrob Chemother; 1987 Nov; 20(5):663-9. PubMed ID: 3501422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and dose recommendations of carumonam in renal failure.
    Koeppe P; Höffler D; Strobel K
    Arzneimittelforschung; 1987 Jan; 37(1):65-9. PubMed ID: 3566860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carumonam in the treatment of severe and complicated urinary tract infections.
    Kotilainen P; Huovinen P; Hänninen P
    Chemioterapia; 1987 Jun; 6(2 Suppl):514-5. PubMed ID: 3509487
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effects of beta-lactamases on the antibacterial activity of carumonam and aztreonam against Klebsiella sp. in comparison with 4 other beta-lactams].
    Labia R; Morand A; Pitton JS; Philippin JL; Fournier P
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):796-9. PubMed ID: 3309817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The anti-microbial activity, beta-lactamase stability, and disk diffusion susceptibility testing of carumonam (RO 17-2301, AMA-1080), a new monobactam.
    Jones RN; Barry AL; Thornsberry C; Fuchs PC; Packer RR
    Am J Clin Pathol; 1986 Nov; 86(5):608-18. PubMed ID: 3096130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative in-vitro activity of cefodizime, cefpirome, carumonam and RU-28965 with other antimicrobials against anaerobes.
    Pascual A; Borobio V; Garcia-Iglesias MC; Perea EJ
    J Antimicrob Chemother; 1987 May; 19(5):701-3. PubMed ID: 3610904
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative in vitro activity of carumonam with gentamicin and other beta-lactam antimicrobials: a multicentric study.
    Martín-Luengo F; Baquero F; Cisterna R; García de Lomas J; García-Rodriguez J; Gobernado M; Gómez Lus R; Perea E; Piedrola G; Roy C
    Chemioterapia; 1987 Jun; 6(2 Suppl):115-6. PubMed ID: 3334551
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative in vitro activity of carumonam (Ro 17-2301/AMA-1080), a new monobactam, and ceftriaxone against aerobic or facultative gram-negative isolates.
    Barclay CA; Iribarren MA; Goldberg M; Traballi CA; Casellas JM
    Chemotherapy; 1987; 33(3):165-71. PubMed ID: 3595259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carumonam and cefotiam in the treatment of complicated urinary tract infection (UTI): a randomized study.
    Westenfelder M; Frankenschmidt A; Pelz K
    Chemioterapia; 1987 Jun; 6(2 Suppl):515-6. PubMed ID: 3334612
    [No Abstract]   [Full Text] [Related]  

  • 20. In vitro and in vivo experience with carumonam: a preliminary report.
    Kanellakopoulou K; Manta M; Tsagaraki C; Giamarellou H
    J Chemother; 1989 Jul; 1(4 Suppl):125. PubMed ID: 16312334
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.